A relatively scant amount of clinical data has suggested an oncogenic role for SIRT1 in breast cancer [40]–[43], however many breast cancer cell lines have lost Sirt1 alleles or contain mutations in the Sirt1 gene, suggesting a role as a non-classical tumor suppressor [44]. This evidence concerns the gene SIRT1 and neoplasm.